Virulence potential of Group A streptococci isolated from throat cultures of children from north India

Indian Journal of Medical Research

Volumn 133, Issue 6, 2011, Pages 674-680

  Dhanda, V ^a   Vohra, H ^b   Kumar, R ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b Australian National University   (Australia)

Author keywords

Adherence; Group A streptococci; Invasion; Pharyngitis; Virulence

Indexed keywords

BACTERIAL PROTEIN; OPACITY FACTOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CELL STRAIN HEPG2; CHILD; DISEASE CARRIER; DISEASE SEVERITY; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; INDIA; MAJOR CLINICAL STUDY; OPSONIZATION; PHAGOCYTOSIS; PHARYNGITIS; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; STREPTOCOCCUS GROUP A; THROAT CULTURE;

EID: 80053021403     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470-511.
2. Carapetis JR, Steer AC, Mulholand EK, Weber M. The global burben of group A streptococcal diseases. Lancet Infect Dis 2005; 5: 685-94.
3. Heath A, Di Diita VJ, Barg NL, Engleberg NC. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin sand pyrogenic exotoxin B. Infect Immun 1999; 67: 5298-305.
4. Hynes W. Virulence factors of the group A streptococci and genes that regulate their expression. Front Biosci 2004; 9: 3399-433.
5. LaPenta D, Rubens C, Chi E, Cleary PP. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci USA 1994; 91: 12115-9.
6. Osterlund A, Popa R, Nikkilä T, Scheynius A, Engstrand L. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 1997; 107: 640-7.
7. Lancefield RC. Differentiation of group A streptococci with a common R antigen into three serological types, with a special reference to the bactericidal test. J Exp Med 1957; 106: 525-44.
8. Sharma M, Shah B, Dhaliwal RS, Kumar R, Brahmadathan KN, Vohra H, et al. Heterogeneity of community based pediatric GAS isolates from India: Challenges to the multivalent vaccine approach. In: Sriprakash KS, editor. Streptococci - New insights into an old enemy. Netherlands: Elsevier International Congress Series, 1289; 2006. p. 49-53.
9. Dey N, McMillan DJ, Yarwood PJ, Joshi RM, Kumar R, Good MF, et al. High diversity of group A streptococcal emm types in an Indian community: the need to tailor multivalent vaccines. Clin Infect Dis 2005; 40: 46-51.
10. Krause RM. A half-century of streptococcal research: then & now. Indian J Med Res 2002; 115: 215-41.
11. Kumar R, Vohra H, Chakraborty A, Sharma YP, Bandhopadhya S, Dhanda V, et al. Epidemiology of group A streptococcal pharyngitis & impetigo: a cross sectional and follow-up study in a rural community of northern India. Indian J Med Res 2009; 130: 765-71.
12. Nandi S, Kumar R, Ray P, Vohra H, Ganguly NK. Clinical score card for diagnosis of group A streptococcal sore throat. Indian J Pediatr 2002; 69: 471-5.
13. Johnson DR, Kaplan EL. Laboratory diagnosis of group A streptococcal infections: a laboratory manual. Geneva: World Health Organization; 1996. p. 16-9.
14. Maxted WR. The use of bacitracin for identifying group A haemolytic streptococci. J Clin Pathol 1953; 6: 224-6.
15. Johnson DR, Kaplan EL. Microtechnique for serum opacity factor characterization of group A streptococci adaptable to the use of human sera. J Clin Microbiol 1988; 26: 2025-30.
16. Sethman CR, Doyle RJ, Cowan MM. Flow cytometric evaluation of adhesion of Streptococcus pyogenes to epithelial cells. J Microbiol Methods 2002; 51: 35-42.
17. Sela S, Neeman R, Keller N, Barzilai A. Relationship between asymptomatic carriage of Streptococcus pyogenes and the ability of the strains to adhere to and be internalized by cultured epithelial cells. J Med Microbiol 2000; 49: 499-502.
18. Jadoun J, Ozeri V, Burstein E, Skutelsky E, Hanski E, Sela S. Protein F1 is required for efficient entry of Streptococcus pyogenes into epithelial cells. J Infect Dis 1998; 178: 147-58.
19. Isberg RR, Falkow S. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature (London) 1985; 317: 262-4.
20. Rubens CE, Smith S, Hulse M, Chi EY, van Belle G. Respiratory epithelial cell invasion by group B streptococci. Infect Immun 1992; 60: 5157-63.
21. Molinari G, Chhatwal GS. Invasion and survival of Streptococcus pyogenes in eukaryotic cells correlates with the source of the clinical isolates. J Infect Dis 1998; 177: 1600-7.
22. Stollerman GH. Rheumatic fever.Lancet 1997; 349: 935-42.
23. Kreikemeyer B, Oehmcke S, Nakata M, Hoffrogge R, Podbielski A. Streptococcus pyogenes fibronectin binding protein F2: expression profile, binding characteristics, and impact on eukaryotic cell interactions. J Biol Chem 2004; 279: 15850-9.
24. Hasty DL, Ofek I, Courtney HS, Doyle RJ. Multiple adhesins of streptococci. Infect Immun 1992; 60: 2147-52.
25. Kaplan EL, Chhatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis 2006; 43: 1398-406.
26. Bronze MS, Dale JB. The reemergence of serious group A streptococcal infections and acute rheumatic fever. Am J Med Sci 1996; 311: 41-54.
27. Bennet-Wood VR, Carapetis JR, Robins-Browne RM. Ability of clinical isolates of group A streptococci to adhere to and invade HEp-2 epithelial cells. J Med Microbiol 1998; 47: 899-906.
28. Gladstone P, Jesudason MV, Sridharan G. Invasive properties of south Indian strains of Streptococcus pyogenes in a HEp-2 cell model. Clin Microbiol Infect 2003; 9: 1031-4.
29. Hagman MM, Dale JB, Stevens DL. Comparison of adherence to and penetration of a human laryngeal epithelial cell line by group A streptococci of various M protein types. FEMS Immunol Med Microbiol 1999; 23: 195-204.
30. de-Malmanche SA, Martin DR. Protective immunity to the group A streptococcus may be only strain specific. Med Microbiol Immunol 1994; 183: 299-306.
31. Medina E, Rohde M, Chhatwal GS. Intracellular survival of Streptococcus pyogenes in polymorphonuclear cells results in increased bacterial virulence. Infect Immun 2003; 71: 5376-80.
32. Villaseñor-Sierra A, McShan WM, Salmi D, Kaplan KL, Johnson DR, Stevens DL. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera. J Infect Dis 1999; 180: 1921-8.